TITLE

Efficacy of Tadalafil De-Escalation in the Treatment of Psychogenic Erectile Dysfunction

AUTHOR(S)
Li, Guangyu; Lan, Haiyan; Liang, Jihong; Zhang, Chengmei; Huang, Cunchao
PUB. DATE
March 2017
SOURCE
Urologia Internationalis;Mar2017, Vol. 98 Issue 2, p205
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: To assess the efficacy of tadalafil de-escalation in the therapeutic effects of psychogenic erectile dysfunction (ED) during the 3 months extension phase. Methods: A total of 90 men with mild to severe psychogenic ED were randomly divided into 2 groups: tadalafil 5 mg group and tadalafil de-escalation group. Efficacy assessments included the 5-item version of International Index of Erectile Function (IIEF-5), the Sexual Encounter Profile (SEP) questionnaires, Psychological and Interpersonal Relationship Scales (PAIRS), Erection Hardness Score (EHS). Results: Compared with the baseline, tadalafil 5 mg and de-escalation groups enhanced all efficacy outcomes. Patients receiving tadalafil 5 mg and de-escalation experienced a significant mean improvement in the psychogenic erectile function domain of the IIEF-5 from the baseline (p < 0.01). The mean change from baseline was significantly higher for the tadalafil de-escalation group than for the tadalafil 5 mg group (p < 0.05). Response to SEP3, PAIRS and EHS was significantly higher in the tadalafil de-escalation group than in the tadalafil 5 mg group (p < 0.05). The severity of ED in the tadalafil de-escalation group had reduced after treatment. It was also significantly better than those in the tadalafil 5 mg group (p < 0.05). Conclusion: Tadalafil de-escalation significantly improved the erectile function among psychogenic ED patients. This implies that tadalafil de-escalation treatment for psychogenic ED is worthy of further clinical practice and research.
ACCESSION #
121924288

 

Related Articles

  • Efficacy and Safety of Tadalafil Once-a-Day versus Tadalafil On-Demand in Patients with Erectile Dysfunction: A Systematic Review and Meta-Analyses. Peng, Zhufeng; Yang, Lu; Dong, Qiang; Wei, Qiang; Liu, Liangren; Yang, Bo // Urologia Internationalis;Oct2017, Vol. 99 Issue 3, p343 

    Introduction: To compare the efficacy and safety between tadalafil once-a-day and tadalafil on-demand dosing regimen in patients with ED. Materials and Methods: A systematic search of Medline, Embase, and Cochrane Library was performed to identify all randomized controlled trials (RCTs) that...

  • The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction. Gacci, Mauro; Salvi, Matteo; Sebastianelli, Arcangelo; Vignozzi, Linda; Corona, Giovanni; McVary, Kevin T.; Kaplan, Steven A.; Maggi, Mario; Carini, Marco; Oelke, Matthias // Research & Reports in Urology;Apr2013, Vol. 5, p99 

    A strong and independent association between lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) and erectile dysfunction (ED) has been widely evidenced in several clinical epidemiologic studies. Preclinical animal models have provided a great deal of information...

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // OB/GYN Clinical Alert;Sep2013 Clincal Briefs, p17 

    The article focuses on a study related to the safety and efficacy of once daily tadalafil (TAD-QD) in doses ranging from 2.5-10.0 miligram per day and also highlights that TAD-QD has more than doubled the rates of successful intercourse.

  • Tadalafil.  // AHFS Consumer Medication Information;Aug2020, p1 

    Tadalafil (Cialis) is used to treat erectile dysfunction (ED, impotence; inability to get or keep an erection), and the symptoms of benign prostatic hyperplasia (BPH; an enlarged prostate) which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying),...

  • Sustained Efficacy and Safety of Vardenafil for Treatment of Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Study. Valiquette, Luc; Young, Jay M.; Moncada, Ignacio; Porst, Hartmut; Vézina, Jean-Guy; Stancil, Britt-Nicole; Edmunds, Katharine; Montorsi, Francesco // Mayo Clinic Proceedings;Oct2005, Vol. 80 Issue 10, p1291 

    OBJECTIVE: To evaluate the reliability, efficacy, and safety of vardenafil, 10 mg, for patients with erectile dysfunction. PATIENTS AND METHODS: Vardenafil-naive patients completed a 4-week treatment-free run-in phase and a 1-week single-dose vardenafil (10 rag) open-label challenge phase....

  • Patient-Reported Urinary Incontinence and Erectile Dysfunction Following Radical Prostatectomy: Results from the European Prostate Centre Innsbruck. Geiger-Gritsch, Sabine; Oberaigner, Wilhelm; Mühlberger, Nikolai; Siebert, Uwe; Ladurner, Michael; Klocker, Helmut; Horninger, Wolfgang // Urologia Internationalis;May2015, Vol. 94 Issue 4, p419 

    Introduction: Urinary and erectile functions were assessed by using self-administered validated questionnaires in patients undergoing radical prostatectomy. Materials and Methods: In a prospective observational study, a total of 253 consecutive patients diagnosed with clinically localised...

  • Effects of Testosterone Replacement on Response to Sildenafil Citrate. Smoger, Steven; Seftel, Allen D.; Hackett, Geoffrey; Aversa, Antonio; Jannini, Emmanuele A.; Maggi, Mario; Lenzi, Andrea; Spitzer, Matthew; Basaria, Shehzad; Travison, Thomas G.; Bhasin, Shalender // Annals of Internal Medicine;4/2/2013, Vol. 158 Issue 7, p569 

    Several letters to the editor and a response from the authors are presented to the article "Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial" by Spitzer and colleagues in the 2012 issue.

  • Microvascular Complications in Diabetic Erectile Dysfunction. Vardi, Yoram // Diabetes Care;Nov2009 Supplement, Vol. 32, pS420 

    The article examines the potential of phosphodiesterase type 5 (PDE5) inhibitors to effectively treat microvascular complications in erectile dysfunction (ED) in diabetic men. It notes the use of the inhibitors as first-line treatment for ED despite of its etiology. It cites key issues that need...

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // Neurology Alert;Sep2013 Clinical Briefs, p17 

    The article discusses research on the efficacy and safety of tadalafil in restoring sexual function in men, which was conducted by A.D. Seftel and colleagues and published in the 2013 issue of the "International Journal of Impotence Research."

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics